Noura Abbas, Gary Goldman, Layal Sharrouf. "Real-world comparative safety and outcomes of ribociclib versus palbociclib in hormone receptor-positive, HER2-negative metastatic breast cancer: A propensity score–matched sensitivity analysis.." Journal of Clinical Oncology, 2026. doi:10.1200/jco.2026.44.16_suppl.1099